AarthiGaneshShenoyMD

Oncology • Washington, DC

Physician

Join to view full profile

Dr. Shenoy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Shenoy's full profile

Already have an account?

Office
110 Irving St Nw # 2a38
Washington, DC 20010
Phone+1 202-877-2844

Education & Training

National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2004 - 2007
University of California (San Diego) Medical CenterResidency, Internal Medicine, 1997 - 2000
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1997

Certifications & Licensure

CA State Medical License 1999 - Present
DC State Medical License 2008 - 2024
MD State Medical License 2010 - 2023
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification ARIA Medical Oncology EMR, Varian Medical Systems, 2012, 2014

Clinical Trials

Safety and Anti-Disease Activity of Oral Tosedostat (CHR-2797) in Elderly Subjects With Refractory or Relapsed AML Start of enrollment: 2009 Oct 01
Completed
Phase 2
Oral Rigosertib in Low Risk MDS Patients Refractory to ESAs Start of enrollment: 2013 Jul 01
Completed
Phase 2
Convalescent Plasma to Limit SARS-CoV-2 Associated Complications Start of enrollment: 2020 Jun 03
Completed
Phase 2

Publications & Presentations

PubMed

38 citations
T Cell Depleted Peripheral Blood Stem Cell Allotransplantation with T Cell Add Back for Patients with Hematological Malignancies: Effect of Chronic GVHD on Outcome
Aldemar Montero, Bipin N. Savani, Aarthi Shenoy, Elizabeth J. Read, Charles S. Carter
Biology of Blood and Marrow Transplantation. 2006-12-01
159 citations
Early Outpatient Treatment for Covid-19 with Convalescent Plasma.
David J Sullivan, Kelly A Gebo, Shmuel Shoham, Evan M Bloch, Bryan Lau
The New England Journal of Medicine. 2022-05-05
6 citations
Clinical and biological predictors of outcome following relapse of CML post-allo-SCT.
Natasha A. Jain, Sawa Ito, Xin Tian, Roger Kurlander, Minoo Battiwalla
Bone Marrow Transplantation. 2015-02-07

Abstracts/Posters

Virologic Clearance of Hepatitis C Is Associated with Improved Outcomes in African American Patients with Lymphoma
Aarthi Shenoy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

MedStar Wants Recovered Coronavirus Patients to Donate PlasmaMay 15th, 2020
Charles and Mary Latham Fund Awards Three Research Grants to MedStar Health Research InstituteFebruary 9th, 2016